Caracterización de variantes genéticas de LDLR y PCSK9 para el diagnóstico de hipercolesterolemia familiar (FH)

Rodríguez Mariblanca, Isabel (2019). Caracterización de variantes genéticas de LDLR y PCSK9 para el diagnóstico de hipercolesterolemia familiar (FH). Proyecto Fin de Carrera / Trabajo Fin de Grado, E.T.S. de Ingeniería Agronómica, Alimentaria y de Biosistemas (UPM), Madrid.

Description

Title: Caracterización de variantes genéticas de LDLR y PCSK9 para el diagnóstico de hipercolesterolemia familiar (FH)
Author/s:
  • Rodríguez Mariblanca, Isabel
Contributor/s:
  • Rodríguez Novoa, Sonia
  • Rodríguez Jiménez, Carmen
  • Torres Lacruz, Miguel Ángel
Item Type: Final Project
Degree: Grado en Biotecnología
Date: July 2019
Subjects:
Faculty: E.T.S. de Ingeniería Agronómica, Alimentaria y de Biosistemas (UPM)
Department: Biotecnología - Biología Vegetal
Creative Commons Licenses: Recognition - No derivative works - Non commercial

Full text

[img]
Preview
PDF - Requires a PDF viewer, such as GSview, Xpdf or Adobe Acrobat Reader
Download (1MB) | Preview

Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant disease of lipid metabolism caused by defects in the genes LDLR, PCSK9, APOB y LDLRAP1. The prevalence of heterozygous familial hypercholesterolemia is estimated between 1/200 and 1/250, and the prevalence of homozygosis familial hypercholesterolemia is estimated in 1/160.000-300.000. It is a genetic disease characterized by high levels of cholesterol-low-density lipoprotein (c-LDL) in plasma, which increases the risk of premature coronary heart disease (CHD). Therefore, early detection of patients with FH allows the initiation of adequate treatment, reducing the risk of CHD. Genetic analysis was performed by Next Generation Sequencing (NGS) using a customized panel of 198 genes in DNA samples of 180 subjects with a clinical diagnosis of probable or definitive FH using the “Dutch Lipid Clinic Network” (DLCN) criteria. Performing a bioinformatic analysis with the aim of finding new interesting genetic variants of the PCSK9 and LDLR genes. Variants of the LDLR gene, and gain-of-function (GOF) variants of the PCSK9 gene are important in FH. As no new variants of the PCSK9 gene were found, only LDLR variants found in patients were validated functionally in hamster ovarian cells (CHO-ldlA7). Low-density lipoprotein receptor (LDLR) activity was measure by flow cytometry, LDLR expression was detected by immunofluorescence and western blot, and colocalization LDLR-Dil-LDL by immunofluorescence. Five variants of the LDLR gene were tested, two of them new, c.640 T>C;p.(Trp214Gly) and c.1369 G>C;p.(Asp457His), and three of them previously described, c.148 G>T;p.(Ala50Ser), c.889 A>C;p.(Asn297His), and c.967 G>A;p.(Gly323Ser). Finally, the variants c.640 T>C;p.(Trp214Gly), c.889 A>C;p.(Asn297His), and c.967 G>A;p.(Gly323Ser) were classified as pathogenic, and the variants c.148 G>T;p.(Ala50Ser) and c.1369 G>C;p.(Asp457His) as benign. The functional in vitro characterization of rare variants at the LDLR and PCSK9 is a useful tool to classify the new variants avoiding the classification as “uncertain significant variants” (VUS). This approach allows to confirm the genetic diagnosis of FH, and therefore, carry out cascade family screening.

More information

Item ID: 57121
DC Identifier: http://oa.upm.es/57121/
OAI Identifier: oai:oa.upm.es:57121
Deposited by: Biblioteca ETSI Agrónomos
Deposited on: 29 Oct 2019 13:34
Last Modified: 29 Oct 2019 13:34
  • Logo InvestigaM (UPM)
  • Logo GEOUP4
  • Logo Open Access
  • Open Access
  • Logo Sherpa/Romeo
    Check whether the anglo-saxon journal in which you have published an article allows you to also publish it under open access.
  • Logo Dulcinea
    Check whether the spanish journal in which you have published an article allows you to also publish it under open access.
  • Logo de Recolecta
  • Logo del Observatorio I+D+i UPM
  • Logo de OpenCourseWare UPM